102 related articles for article (PubMed ID: 10738559)
1. Quantification of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines.
Wybranietz WA; Prinz F; Spiegel M; Schenk A; Bitzer M; Gregor M; Lauer UM
J Gene Med; 1999; 1(4):265-74. PubMed ID: 10738559
[TBL] [Abstract][Full Text] [Related]
2. Intercellular spread of GFP-VP22.
Aints A; Dilber MS; Smith CI
J Gene Med; 1999; 1(4):275-9. PubMed ID: 10738560
[TBL] [Abstract][Full Text] [Related]
3. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
4. Intercellular trafficking of VP22-GFP fusion proteins.
Elliott G; O'Hare P
Gene Ther; 1999 Jan; 6(1):149-51. PubMed ID: 10341888
[TBL] [Abstract][Full Text] [Related]
5. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
[TBL] [Abstract][Full Text] [Related]
6. VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo.
Zender L; Kühnel F; Köck R; Manns M; Kubicka S
Cancer Gene Ther; 2002 Jun; 9(6):489-96. PubMed ID: 12032659
[TBL] [Abstract][Full Text] [Related]
7. Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo.
Zavaglia D; Lin EH; Guidetti M; Pluquet O; Hainaut P; Favrot MC; Coll JL
J Gene Med; 2005 Jul; 7(7):936-44. PubMed ID: 15754307
[TBL] [Abstract][Full Text] [Related]
8. Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells.
Fang B; Xu B; Koch P; Roth JA
Gene Ther; 1998 Oct; 5(10):1420-4. PubMed ID: 9930348
[TBL] [Abstract][Full Text] [Related]
9. Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport.
Xiong F; Xiao S; Yu M; Li W; Zheng H; Shang Y; Peng F; Zhao C; Zhou W; Chen H; Fang L; Chamberlain JS; Zhang C
BMC Neurosci; 2007 Jul; 8():50. PubMed ID: 17617925
[TBL] [Abstract][Full Text] [Related]
10. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death.
Liu CS; Kong B; Xia HH; Ellem KA; Wei MQ
J Gene Med; 2001; 3(2):145-52. PubMed ID: 11318113
[TBL] [Abstract][Full Text] [Related]
11. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.
Aints A; Güven H; Gahrton G; Smith CI; Dilber MS
Gene Ther; 2001 Jul; 8(14):1051-6. PubMed ID: 11526452
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase.
Roy V; Qiao J; de Campos-Lima P; Caruso M
Gene Ther; 2005 Jan; 12(2):169-76. PubMed ID: 15483667
[TBL] [Abstract][Full Text] [Related]
13. Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene.
Wybranietz WA; Gross CD; Phelan A; O'Hare P; Spiegel M; Graepler F; Bitzer M; Stähler P; Gregor M; Lauer UM
Gene Ther; 2001 Nov; 8(21):1654-64. PubMed ID: 11895004
[TBL] [Abstract][Full Text] [Related]
14. Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy.
Bian J; Popovic ZB; Benejam C; Kiedrowski M; Rodriguez LL; Penn MS
Circ Res; 2007 Jun; 100(11):1626-33. PubMed ID: 17495229
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of VP22 spread in tissue culture.
Brewis N; Phelan A; Webb J; Drew J; Elliott G; O'Hare P
J Virol; 2000 Jan; 74(2):1051-6. PubMed ID: 10623773
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
Roeder GE; Parish JL; Stern PL; Gaston K
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
[TBL] [Abstract][Full Text] [Related]
17. Evidence for intercellular trafficking of VP22 in living cells.
Lemken ML; Wolf C; Wybranietz WA; Schmidt U; Smirnow I; Bühring HJ; Mack AF; Lauer UM; Bitzer M
Mol Ther; 2007 Feb; 15(2):310-9. PubMed ID: 17235309
[TBL] [Abstract][Full Text] [Related]
18. VP22 enhances antibody responses from DNA vaccines but not by intercellular spread.
Perkins SD; Hartley MG; Lukaszewski RA; Phillpotts RJ; Stevenson FK; Bennett AM
Vaccine; 2005 Mar; 23(16):1931-40. PubMed ID: 15734065
[TBL] [Abstract][Full Text] [Related]
19. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
Lemken ML; Graepler F; Wolf C; Wybranietz WA; Smirnow I; Schmidt U; Gregor M; Bitzer M; Lauer UM
Int J Oncol; 2007 May; 30(5):1153-61. PubMed ID: 17390017
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the nuclear localization and nuclear export signals of bovine herpesvirus 1 VP22.
Zheng C; Brownlie R; Babiuk LA; van Drunen Littel-van den Hurk S
J Virol; 2005 Sep; 79(18):11864-72. PubMed ID: 16140763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]